Form D — Trevarx Biomedical, Inc.
0001783904-25-000003 · filed Aug 4, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $750,000
- Reported amount sold
- $350,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Trevarx Biomedical, Inc.
- CIK
- 1783904
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2929 ARCH STREET, 3RD FLOOR
PHILADELPHIA, Pennsylvania 19104 - Phone
- (206) 949-4956
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jean Cho · Executive OfficerPhiladelphia, Pennsylvania Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗